Allogene Therapeutics shares owned by Rhenman & Partners Asset Management AB
Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Rhenman & Partners Asset Management AB
from 13F filings
Historical chart of Rhenman & Partners Asset Management AB investment in Allogene Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Allogene Therapeutics held by Rhenman & Partners Asset Management AB consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Allogene Therapeutics by Rhenman & Partners Asset Management AB
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $951k | 300k | 3.17 |
| 2023-06-30 | $1.5M | 300k | 4.97 |
| 2023-03-31 | $1.5M | 300k | 4.97 |
| 2022-12-31 | $2.1M | 340k | 6.29 |
| 2022-09-30 | $3.5M | 340k | 10.30 |
| 2022-06-30 | $4.0M | 350k | 11.40 |
More positions owned by Rhenman & Partners Asset Management AB
Cigna Corp (CI)
View all positions for Rhenman & Partners Asset Management AB